Literature DB >> 21526940

Chronic fatigue syndrome, XMRV and blood safety.

Roger Y Dodd1.   

Abstract

In the past few months, there has been public discussion relating to a new perspective on blood safety and specifically upon measures to prevent or discourage donation by individuals with a diagnosis of myalgic encephalopathy-chronic fatigue syndrome. This reflects an intriguing interplay between science, public health and public concern and illustrates some of the difficulties of making decisions in the face of uncertainty and inadequate information.

Entities:  

Mesh:

Year:  2011        PMID: 21526940     DOI: 10.2217/fmb.11.24

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  2 in total

1.  Problems with precaution: the transfusion medicine experience.

Authors:  Kumanan Wilson; Katherine M Atkinson; Dean A Fergusson; Adalsteinn Brown; Alan Forster; Malia S Q Murphy; Alan T Tinmouth; Jennifer Keelan
Journal:  J Risk Res       Date:  2017-07-29

2.  The use of preliminary scientific evidence in public health: a case study of XMRV.

Authors:  Kumanan Wilson; Katherine Atkinson; Jennifer Keelan
Journal:  PLoS Med       Date:  2014-04-08       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.